Ripk1 and haematopoiesis: a case for LUBAC and Ripk3.
Ripk1 and haematopoiesis: a case for LUBAC and Ripk3.
复制标题
DOI:
10.1038/s41418-018-0135-2
复制
发表时间:
2018-08
影响因子:
12.4
通讯作者:
Meier P
中科院分区:
文献类型:
--
作者:
Annibaldi A;Meier P
Although long recognized as a component of inflamed tissues, the potential role of cell death as an active component that contributes to tissue homeostasis, inflammation and disease pathogenesis has only recently gained attention [1]. The notion that cell death components are hard-wired into inflammatory signaling pathways indicates that such death components act as positive regulators of tissue homeostasis, enhancing the resilience of epithelia to tissue stress [1, 2] Dedicated sensors have evolved to detect different stressors and induce adaptive responses. Receptorinteracting serine/threonine-protein kinase 1 (Ripk1) represents such sensor, functioning as signaling node in regulating adaptive responses to tissue stress [1]. Ripk1 is activated following a variety of input signals, such as in response to tumor necrosis factor (TNF) family cytokines, pattern recognition receptors and interferons. Ripk1 can activate mitogen-activated protein kinases, nuclear factorκB (NF-κB) and apoptotic as well as necrotic cell death [1].Ripk1 mediates these effects in a kinase-dependent and/or scaffold-dependent manner. While the scaffold function of Ripk1 maintains tissue homeostasis [1], the kinase activity of Ripk1 is required for necroptosis, and, depending on the cellular context, apoptosis [3, 4]. Ripk1 is tightly controlled by ubiquitylation, phosphorylation and caspase-mediated cleavage [1, 5, 6]. Too much or too little Ripk1 activity can lead to cell death, chronic inflammation and lethality. Understanding how Ripk1 is regulated has important implications for normal development and disease pathologies, such as chronic inflammation and cancer. But it also offers novel opportunities for immuno-oncology as Ripk1 and NF-κB signaling is required for antigen cross-priming of CD8+ T cells [7].
登录
查看更多内容
影响因子:
16
作者:
Annibaldi A;Wicky John S;Vanden Berghe T;Swatek KN;Ruan J;Liccardi G;Bianchi K;Elliott PR;Choi SM;Van Coillie S;Bertin J;Wu H;Komander D;Vandenabeele P;Silke J;Meier P
通讯作者:
Meier P
影响因子:
9
作者:
Geserick P;Wang J;Schilling R;Horn S;Harris PA;Bertin J;Gough PJ;Feoktistova M;Leverkus M
通讯作者:
Leverkus M
DOI:
10.4049/jimmunol.1400499
发表时间:
2014-06-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Berger SB;Kasparcova V;Hoffman S;Swift B;Dare L;Schaeffer M;Capriotti C;Cook M;Finger J;Hughes-Earle A;Harris PA;Kaiser WJ;Mocarski ES;Bertin J;Gough PJ
通讯作者:
Gough PJ
影响因子:
16
作者:
Jaco I;Annibaldi A;Lalaoui N;Wilson R;Tenev T;Laurien L;Kim C;Jamal K;Wicky John S;Liccardi G;Chau D;Murphy JM;Brumatti G;Feltham R;Pasparakis M;Silke J;Meier P
通讯作者:
Meier P
影响因子:
8.8
作者:
Peltzer, Nieves;Rieser, Eva;Walczak, Henning
通讯作者:
Walczak, Henning